Interaction of sickle cell trait and glucose-6-phosphate dehydrogenase deficiency in Cameroon

Human Heredity
|January 1, 1980
PubMed

Insights

Sickle cell trait may benefit individuals with glucose-6-phosphate dehydrogenase (G6PD) deficiency. This finding suggests sickle hemoglobin offers protection against oxidative stress, potentially preventing severe hemolytic disease in G6PD-deficient males.

Area of Science:

  • Hematology
  • Genetics
  • Biochemistry

Background:

  • Glucose-6-phosphate dehydrogenase (G6PD) deficiency is a common genetic disorder.
  • Sickle cell trait is another prevalent genetic condition, particularly in certain populations.
  • The interaction between G6PD deficiency and sickle cell trait has been previously debated.

Purpose of the Study:

  • To determine the prevalence of G6PD deficiency and sickle cell trait in Cameroonian males.
  • To compare the observed co-occurrence of these conditions with expected frequencies.
  • To investigate the potential protective effect of sickle hemoglobin on G6PD deficiency.

Main Methods:

  • Prevalence study involving 371 Cameroonian males.
  • Analysis of 668 male blood donors in Chicago for comparison.
  • Statistical analysis to compare observed vs. expected frequencies of co-inheritance.

Main Results:

  • Significantly higher than expected co-occurrence of sickle cell trait and G6PD deficiency in Cameroon (p < 0.05).
  • Elevated G6PD levels observed in G6PD-deficient males with sickle cell trait.
  • A trend towards higher than expected co-occurrence in the Chicago population (p > 0.30).

Conclusions:

  • Sickle hemoglobin may offer a beneficial effect on G6PD deficiency.
  • This protective effect might stem from enhanced red blood cell resistance to oxidative stress.
  • The findings challenge previous hypotheses suggesting a detrimental interaction.

Related Concept Videos

Multiple Allele Traits01:49

Multiple Allele Traits

The Concept of Multiple Allelism
Glucose Transporters01:27

Glucose Transporters

Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Malaria01:29

Malaria

Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...